213 results on '"Shingai, Tatsushi"'
Search Results
2. Obstructive shock and cardiac arrest due to diaphragmatic hernia after esophageal surgery: a case report
3. Phase II trial evaluating the long-term efficacy and peripheral sensory neuropathy of capecitabine plus oxaliplatin (XELOX) as adjuvant therapy in Japanese patients with operated stage III colon cancer
4. Clinicopathological features of appendiceal goblet cell adenocarcinoma in Japan: a multicenter retrospective study
5. Impact of early tumor shrinkage on quality of life in patients treated with first-line cetuximab plus chemotherapy for unresectable metastatic colorectal cancer: results of Phase II QUACK trial
6. Safety and feasibility of pain management using high-dose oral acetaminophen for enhanced recovery after colorectal cancer surgery
7. The Phase II Study of Panitumumab in Chemotherapy-Naïve Frail or Elderly Patients with RAS Wild-type Colorectal Cancer: OGSG 1602 Final Results.
8. Prognostic significance of a preoperative magnetic resonance imaging assessment of the distance of mesorectal extension in clinical T3 lower rectal cancer
9. The Phase II Study of Panitumumab in Chemotherapy-Naïve Frail or Elderly Patients with RAS Wild-type Colorectal Cancer: OGSG 1602 Final Results
10. Additional file 1 of Impact of early tumor shrinkage on quality of life in patients treated with first-line cetuximab plus chemotherapy for unresectable metastatic colorectal cancer: results of Phase II QUACK trial
11. Additional file 2 of Impact of early tumor shrinkage on quality of life in patients treated with first-line cetuximab plus chemotherapy for unresectable metastatic colorectal cancer: results of Phase II QUACK trial
12. Additional file 3 of Impact of early tumor shrinkage on quality of life in patients treated with first-line cetuximab plus chemotherapy for unresectable metastatic colorectal cancer: results of Phase II QUACK trial
13. A twice-daily or a three-times-daily tegafur-uracil and leucovorin calcium regimen as adjuvant therapy in patients with resected colorectal cancer: A phase III study.
14. A case of isolated lateral lymph node recurrence occurring after TME for T1 lower rectal cancer treated with lateral lymph node dissection: report of a case
15. Recurrence of hepatocellular carcinoma presenting as an asymptomatic appendiceal tumor: report of a case
16. Preoperative staging of clinically node-negative esophageal cancer by the combination of 18F-fluorodeoxyglucose positron emission tomography and computed tomography (FDG–PET/CT)
17. Comparison Between Radical Esophagectomy and Definitive Chemoradiotherapy in Patients with Clinical T1bN0M0 Esophageal Cancer
18. Effects of Intraperitoneal Chemotherapy with Mitomycin C on the Prevention of Peritoneal Recurrence in Colorectal Cancer Patients with Positive Peritoneal Lavage Cytology Findings
19. CEA-Antigen and SCC-Antigen mRNA Expression in Peripheral Blood Predict Hematogenous Recurrence After Resection in Patients with Esophageal Cancer
20. Castleman’s Disease of the Rectum: Report of a Case
21. Complete Response of Highly Advanced Colon Cancer with Multiple Lymph Node Metastases to Irinotecan Combined with UFT: Report of a Case
22. Administration Method of Adjuvant Tegafur-Uracil and Leucovorin Calcium in Patients with Resected Colorectal Cancer: A Phase III Study
23. Locoregional and multiple distant metastases after chemoradiation therapy following endoscopic resection for rectal cancer with deep submucosal invasion
24. Staging laparoscopy using ALA-mediated photodynamic diagnosis improves the detection of peritoneal metastases in advanced gastric cancer
25. Brain metastasis from colorectal cancer: Prognostic factors and survival
26. Subtotal gastrectomy for gastric tube cancer after esophagectomy: A safe procedure preserving the proximal part of gastric tube based on intraoperative ICG blood flow evaluation
27. Is routine measurement of amylase concentration in drainage fluid necessary after total gastrectomy for gastric cancer?
28. Preoperative chemoradiation reduces the risk of pancreatic fistula after distal pancreatectomy for pancreatic adenocarcinoma
29. Disagreement between patient‐ and physician‐reported outcomes on symptomatic adverse events as poor prognosis in patients treated with first‐line cetuximab plus chemotherapy for unresectable metastatic colorectal cancer: Results of Phase II QUACK trial
30. Phase II Study of Panitumumab Monotherapy in Chemotherapy-Naïve Frail or Elderly Patients with Unresectable RAS Wild-Type Colorectal Cancer: OGSG 1602
31. Adjuvant Chemotherapy after Neoadjuvant Chemotherapy and Long-term Outcomes of CAPOX Plus Bevacizumab Followed by TME for High-risk Localized Rectal Cancer
32. Postoperative XELOX therapy for patients with curatively resected high-risk stage II and stage III rectal cancer without preoperative chemoradiation: A prospective, multicenter, open-label, single arm phase II study.
33. Patient‐reported symptom burden as a prognostic factor in treatment with first‐line cetuximab plus chemotherapy for unresectable metastatic colorectal cancer: Results of Phase II QUACK trial
34. Phase III Study on the Administration Method of Adjuvant UFT and Leucovorin Calcium in Patients with Resected Colorectal Cancer (Thrice-Daily versus Twice-Daily Regimen)
35. Significance of the Resection of Ovarian Metastasis From Colorectal Cancers
36. Total splenic vein thrombosis after laparoscopic splenectomy: a possible candidate for treatment
37. A novel rabconnectin-3-binding protein that directly binds a GDP/GTP exchange protein for Rab3A small G protein implicated in Ca2+-dependent exocytosis of neurotransmitter
38. Antagonistic and agonistic effects of an extracellular fragment of nectin on formation of E-cadherin-based cell-cell adhesion
39. EMS-2 Postoperative Ileus for Gastroenterological Cancer: A Retrospective, Multicenter Observational Study
40. EMS-1 Perioperative PONV Countermeasures and Future Prospects Along the Goal of ESSENSE Project
41. A prospective Phase II study to examine the relationship between quality of life and adverse events of first‐line chemotherapy plus cetuximab in patients with KRAS wild‐type unresectable metastatic colorectal cancer: QUACK trial
42. EMS-3 Multimodal Antiemetic Management Prevents Early Postoperative Vomiting after Colorectal Surgery on ERAS Protocol
43. Comparison of bleeding risks related to venous thromboembolism prophylaxis in laparoscopic vs open colorectal cancer surgery: a multicenter study in Japanese patients
44. Ten-millimeter advanced transverse colon cancer accompanied by a sessile serrated adenoma and/or polyp
45. Clinicopathological characteristics and prognosis of stage IV colorectal cancer
46. Randomized phase II study of S-1 dosing schedule for resected colorectal cancer
47. Successful treatment of rectal cancer with perineal invasion: Three case reports
48. A Case of Pneumatosis Cystoides Intestinalis Due to Anastomosis Site of Postoperative Colorectal Surgery
49. Visceral fat changes after distal gastrectomy according to type of reconstruction procedure for gastric cancer
50. A Case of the Appendiceal Mucocele Treated by Laparoscopy-Assisted Ileocecal Resection
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.